Arbutus Biopharma Corp: president and CEO Androski Lindsay sold 24,655 shares

What happened Androski Lindsay, president and CEO and a director, disposed of 24,655 common shares to the issuer at $5.00 per share on Oct 1, 2026, for $123,275. The transaction is reported on a Form 4 filed Oct 7, 2026.

Key details

• Transaction date and type: Oct 1, 2026 — disposition to the issuer (code D) at $5.00 per share.
• Total value reported: $123,275.
• Shares owned after the transaction: not stated in the filing.
• Footnote F1: the shares were tendered to the issuer pursuant to the issuer's tender offer; the issuer took up and accepted the common shares for payment on Oct 1, 2026.
• Form 4 filing date: Oct 7, 2026.

Why it may matter

• The filing shows a disposition to the issuer under a tender offer (shares were tendered and accepted on Oct 1, 2026), rather than a market sale or an option exercise.
• A filing does not show why the insider traded or why the company acted.